Your Client Rank:
Loading...
Updated 16-May-2025
Loading quarterly data...
|
Median |
YOY |
High |
Low |
US |
YOY |
RoW |
YOY |
Xolair is also known as omalizumab.
Total Medicare spending of $550m in 2020 represented 44.0% of WW sales. This was made up of $400m from Part B and $151m Part D spending.
Excel Plugin ID: DRUG-1326